Clinical Trial Update: Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of bortezomib and cetuximab in patients with advanced solid tumors across multiple cancer types; the study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Head and Neck Cancer
• Lung Cancer
• Pancreatic Cancer
• Renal Cell Carcinoma
• Soft Tissue Sarcoma

Drugs mentioned

• Bortezomib (bortezomib)
• Cetuximab (cetuximab)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Breast Cancer, Colorectal Cancer | Phase 1 | Status: COMPLETED